I Abubakar1, M T Laundy, C E French, D Shingadia. 1. Tuberculosis Section, Respiratory Diseases Department, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK. ibrahim.abubakar@hpa.org.uk
Abstract
OBJECTIVE: To describe the recent trends in demographic, clinical and microbiological characteristics and outcome of treatment in paediatric cases of tuberculosis. DESIGN: National surveillance study. SETTING: England and Wales. PATIENTS: All children under the age of 16 years reported with tuberculosis to the national enhanced surveillance system between 1999 and 2006 were included. MAIN OUTCOME MEASURES: Proportions, and rates of disease, by demographic characteristics, site of disease, diagnostic delay, culture confirmation, species, drug susceptibility and treatment outcome. RESULTS: 3563 cases of tuberculosis in children were reported between 1999 and 2006. The incidence rate remained stable at around 4.3 per 100,000 (95% CI 4.1 to 4.4). Patients born outside the UK had a tuberculosis rate higher than children born in the UK (37 per 100,000 vs 2.5 per 100,000) and this rate increased over the period. Rates in the black African ethnic group were highest at 88 per 100,000. 60% of children had pulmonary disease, the commonest presentation, but only 948 (27%) had culture confirmed tuberculosis. The median time to diagnosis from onset of symptoms was 37 days (interquartile range 12-89). The proportions of cases with rifampicin, isoniazid and multi-drug resistant isolates were 2.4%, 9.3% and 2.3%, respectively. 88% of children completed treatment and less than 1% died. CONCLUSIONS: Overall rates of tuberculosis in children have remained stable, with the majority completing treatment. Rates are, however, highest in children not born in the UK, particularly among certain ethnic minority groups. Levels of drug resistance are also high.
OBJECTIVE: To describe the recent trends in demographic, clinical and microbiological characteristics and outcome of treatment in paediatric cases of tuberculosis. DESIGN: National surveillance study. SETTING: England and Wales. PATIENTS: All children under the age of 16 years reported with tuberculosis to the national enhanced surveillance system between 1999 and 2006 were included. MAIN OUTCOME MEASURES: Proportions, and rates of disease, by demographic characteristics, site of disease, diagnostic delay, culture confirmation, species, drug susceptibility and treatment outcome. RESULTS: 3563 cases of tuberculosis in children were reported between 1999 and 2006. The incidence rate remained stable at around 4.3 per 100,000 (95% CI 4.1 to 4.4). Patients born outside the UK had a tuberculosis rate higher than children born in the UK (37 per 100,000 vs 2.5 per 100,000) and this rate increased over the period. Rates in the black African ethnic group were highest at 88 per 100,000. 60% of children had pulmonary disease, the commonest presentation, but only 948 (27%) had culture confirmed tuberculosis. The median time to diagnosis from onset of symptoms was 37 days (interquartile range 12-89). The proportions of cases with rifampicin, isoniazid and multi-drug resistant isolates were 2.4%, 9.3% and 2.3%, respectively. 88% of children completed treatment and less than 1% died. CONCLUSIONS: Overall rates of tuberculosis in children have remained stable, with the majority completing treatment. Rates are, however, highest in children not born in the UK, particularly among certain ethnic minority groups. Levels of drug resistance are also high.
Authors: Elisabetta Walters; Marieke Magrieta van der Zalm; Megan Palmer; Corné Bosch; Anne-Marie Demers; Heather Draper; Pierre Goussard; Hendrik Simon Schaaf; Sven Olaf Friedrich; Andrew Whitelaw; Robin Warren; Robert P Gie; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2017-09 Impact factor: 2.129
Authors: Megan Palmer; Kenneth S Gunasekera; Marieke M van der Zalm; Julie Morrison; H Simon Schaaf; Pierre Goussard; Anneke C Hesseling; Elisabetta Walters; James A Seddon Journal: Clin Infect Dis Date: 2022-09-29 Impact factor: 20.999
Authors: Helen E Jenkins; Courtney M Yuen; Carly A Rodriguez; Ruvandhi R Nathavitharana; Megan M McLaughlin; Peter Donald; Ben J Marais; Mercedes C Becerra Journal: Lancet Infect Dis Date: 2016-12-08 Impact factor: 25.071
Authors: Muhammad Osman; Kevin Lee; Karen Du Preez; Rory Dunbar; Anneke C Hesseling; James A Seddon Journal: Clin Infect Dis Date: 2017-10-16 Impact factor: 9.079
Authors: Anna Odone; Taavi Tillmann; Andreas Sandgren; Gemma Williams; Bernd Rechel; David Ingleby; Teymur Noori; Philipa Mladovsky; Martin McKee Journal: Eur J Public Health Date: 2014-12-13 Impact factor: 3.367
Authors: Connie G M Erkens; Gerard de Vries; Sytze T Keizer; Erika Slump; Susan van den Hof Journal: BMC Infect Dis Date: 2014-05-31 Impact factor: 3.090